Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Britain's cost agency not ready to back Gilead hepatitis C drug
Yahoo/Reuters
Mon, 06/16/14 - 08:47 pm
Tags:
UK, Gilead Sciences, Sovaldi, hepatitis C
InterMune's A Strong Buy As Esbriet Finally Has The Data Physicians, Patients, And FDA Have Longed For
Seeking Alpha
Sun, 06/15/14 - 06:31 pm
Tags:
InterMune, Esbriet, Actelion, Gilead Sciences
What Is Next For The Hepatitis C Space?
Seeking Alpha
Fri, 06/13/14 - 11:05 am
Tags:
hepatitis C, Conatus Pharmaceuticals, Gilead Sciences, Merck, Idenix
Merck's Acquisition Of Idenix Pharmaceuticals Is An Admission Of Inferiority To Sovaldi Regimens
Seeking Alpha
Tue, 06/10/14 - 07:19 pm
Tags:
Idenix, Merck, M&A, hepatitis C, Sovaldi, Gilead Sciences
Gilead Sciences: Killing The Competition With Sovaldi; But Does This Make Gilead A One-Trick Pony?
Seeking Alpha
Mon, 06/9/14 - 07:53 pm
Tags:
Sovaldi, Gilead Sciences, hepatitis C
Gilead Down On Merck-Idenix Deal, But Little To Fear
Seeking Alpha
Mon, 06/9/14 - 02:50 pm
Tags:
Gilead Sciences, Merck, Idenix, hepatitis C, M&A
HCV players moving after Merck buys Idenix
The Fly on the Wall
Mon, 06/9/14 - 12:01 pm
Tags:
Merck, Gilead Sciences, Idenix, M&A, Achillion, JNJ, AbbVie
Merck “More Formidable” Competitor for Gilead, But Still Years Away
Barron's
Mon, 06/9/14 - 11:58 am
Tags:
Merck, Gilead Sciences, Idenix, M&A, hepatitis C
How Gilead Sciences Can Deliver A Double
Forbes
Fri, 06/6/14 - 10:05 am
Tags:
Gilead Sciences, Sovaldi
What Price Innovation? The Sovaldi Saga
Forbes
Thu, 05/29/14 - 09:43 am
Tags:
innovation, Sovaldi, Gilead Sciences, drug pricing, hepatitis C
Insurers scrutinize drug costs after $84,000 Sovaldi surprise
Yahoo/Reuters
Wed, 05/28/14 - 02:01 pm
Tags:
drug pricing, insurance, Sovaldi, Gilead Sciences
The 3 Biggest Biotech Wins of the Week
Motley Fool
Wed, 05/28/14 - 10:52 am
Tags:
GS-5806, Gilead Sciences, Factor XI inhibitor, Isis Pharmaceuticals, InterMune, pirfenidone, IPF
Recent Developments In Gilead's Non-Hepatitis C Programs
Seeking Alpha
Tue, 05/27/14 - 11:55 am
Tags:
Gilead Sciences, RSV, GS-5806, Viread, TAF, Ranexa, atrial fibrillation
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Tags:
Roche, Gazyva, Imbruvica, JNJ, Gilead Sciences, Sovaldi, mantle cell lymphoma, chronic lymphocytic leukemia, leukemia, Biogen, hepatitis, hepatitus C
Side effect analysis suggests Gilead's hep C wonder Sovaldi is safer than rivals, too
Fierce Pharma
Tue, 05/20/14 - 11:46 am
Tags:
Sovaldi, side effects, hepatitis C, Gilead Sciences
CDC backing for preventive Truvada could multiply Gilead's scripts 50-fold
Fierce Pharma
Thu, 05/15/14 - 11:11 am
Tags:
CDC, Truvada, HIV, Gilead Sciences
ASCO '14 Preview: Blood Cancer Data from Pharmacyclics, Gilead, Abbvie
TheStreet.com
Thu, 05/15/14 - 08:29 am
Tags:
ASCO, Gilead Sciences, AbbVie, Pharmacyclics, Imbruvica, CLL, Idelalisib, mantle cell lymphoma, ABT-199
What's Hurting Biotechnology Stocks?
Seeking Alpha
Tue, 05/13/14 - 11:37 am
Tags:
biotech, Gilead Sciences, InterMune, MannKind, Amgen, Celgene, Biogen Idec
A Physician Compares Gilead's And AbbVie's Hepatitis C Products
Seeking Alpha
Mon, 05/12/14 - 11:15 am
Tags:
Gilead Sciences, AbbVie, hepatitis C, Sovaldi, physicians, Humira
Gilead Announces Results from Phase 2 Study Showing Reduction in Atrial Fibrillation Burden with the Investigational Combination of Ranolazine and Low-Dose Dronedarone
Yahoo/BusinessWire
Sun, 05/11/14 - 10:30 am
Tags:
Gilead Sciences, dronedarone, ranolazine, atrial fibrilation

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.